• Gilberto Eduardo Meza Reyes, Ricardo Esquivel Gómez, Antonio Martínez del Campo Sánchez, Francisco Espinosa-Larrañaga, Miguel Ángel Enrique Martínez Guzmán, Rubén Torres González, Juan Carlos de la Fuente Zuno, Juan Vicente Méndez Huerta, Enrique Villalobos Garduño, José Cymet Ramírez, Efrén Ibarra Hirales, Efraín Díaz Borjón, José Manuel Aguilera Zepeda, Juan Francisco Valles Figueroa, Abraham Majluf-Cruz, and Colegio Mexicano de Ortopedia y Traumatología.
• Instituto Mexicano del Seguro Social, México.
• Gac Med Mex. 2012 Mar 1; 148 (2): 144-52.

AbstractVenous thromboembolism (VTE) is a worldwide public health problem, with an annual incidence of 1-2 cases/1,000 individuals in the general population and a 1-5% associated mortality. Orthopedic surgery is a major surgical risk factor for VTE, but the problem is more important for patients with hip and knee joint replacement, multiple traumatisms, severe damage to the spine, or large fractures. Thromboprophylaxis is defined as the strategy and actions necessary to diminish the risk of VTE in high-risk orthopedic surgery. Antithrombotics may prevent VTE. At the end of this paper, we describe a proposal of thromboprophylaxis actions for patients requiring high-risk orthopedic surgery, based on the opinion of specialists in Orthopedics and Traumatology who work with high-risk orthopedic surgery patients. A search for evidence about this kind of surgery was performed and a 100-item inquiring instrument was done in order to know the opinions of the participants. Then, recommendations and considerations were built. In conclusion, this document reviews the problem of VTE in high-risk orthopedic surgery patients and describes the position of the Colegio Mexicano de Ortopedia y Traumatología related to VTE prevention in this setting.

8 keywords...

hide…